Genesis Pharmaceuticals Enterprises, a US-based pharmaceutical company with its principal operations in China, has launched three traditional Chinese medicines.
The traditional Chinese medicines (TCMs) are Yi Mu Cao Gao, a motherwort herb electuary sticky syrup, Gan Mao Zhi Ke Ke Li, an antipyretic and antitussive granule, and Kang Gu Sui Yan Pian, an osteomyelitis treatment tablet.
The company said that it has recently purchased 22 TCMs with State Food and Drug Administration drug regulatory agency approvals for manufacturing and distribution from Hongrui Pharmaceuticals.
The three TCMs which Genesis is now beginning to market and distribute are the first three products Genesis acquired from Hongrui to be relabeled and sold under Genesis’s brand name ‘Jiangbo’. All three Hongrui products are being sold through the 28 independent distributors used by Genesis.
Wubo Cao, CEO of Genesis, said: We are pleased to launch these three products so quickly after taking control over Hongrui. Generally speaking, TCMs are popular in rural China because they are less expensive than western medicines. We plan to increase our marketing and sales efforts for all of our TCM products in rural areas in conjunction with government plans to expand healthcare services there.